[Discontinuation syndrome associated with antidepressants]

Area of Science:

• Pharmacology
• Neuroscience
• Clinical Psychiatry

Context:

• Antidepressant therapy is widely prescribed for mood disorders.
• Abrupt cessation of antidepressant medication can lead to adverse effects.
• Distinguishing discontinuation syndrome from relapse is crucial for patient management.

Purpose:

• To describe the characteristics of antidepressant discontinuation syndrome.
• To differentiate discontinuation syndrome from relapse or recurrence of the underlying condition.
• To provide guidance on managing antidepressant discontinuation.

Summary:

• Antidepressant discontinuation syndrome involves physical and psychological symptoms emerging within one week and lasting approximately three weeks after stopping medication.
• These symptoms are distinct from a return of the original mood disorder symptoms (relapse or recurrence).
• While often self-limiting, severe cases may require reintroduction of the antidepressant for rapid symptom resolution, highlighting the importance of progressive tapering.

Impact:

• Informing clinicians about the nature and timeline of discontinuation symptoms.
• Guiding the development of best practices for tapering antidepressant medications.
• Improving patient safety and treatment adherence during the cessation of antidepressant therapy.